About GETH
GETH is a Government & Social Sector company based in Spain. Hematopoietic transplant and cellular therapy services are provided in Spain. Its focus areas include Healthcare and Healthcare Foundations.
Company details
Provider of hematopoietic transplant and cellular therapy services. It facilitates the dissemination of scientific knowledge related to these areas, promotes collaborative studies among transplant teams, and provides clear information about procedures and participating centers to patients and families. The organization supports the development and scientific research in the field through the collaboration of various healthcare professionals. It offers clinical guidelines, a biobank, and a job portal for professionals. The group also organizes educational events and training programs.
- Latest Funding Round$22.41K (USD), Grant
Nov 2022
- Investors
Funding Insights of GETH
- Total Rounds 1
- Last Round Grant — $22,413
- First Round $22,413
(Nov 2022)
- Investors Count 1
All 1 funding rounds of GETH with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $22,413 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in GETH
GETH has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for GETH
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of GETH
The website of GETH (geth.es) receives about 8.6K visits a month.
- Monthly visits8.6K
▼ 16.1% vs previous month
Websites whose visitors overlap most with GETH. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genesiscare.com | 100% | 63.7K | #558,186 | View details | |
| clinicaamo.com.br | 48% | 13.5K | #1,808,019 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GETH
GETH is headquartered in Spain.
Provider of hematopoietic transplant and cellular therapy services. It facilitates the dissemination of scientific knowledge related to these areas, promotes collaborative studies among transplant teams, and provides clear information about procedures and participating centers to patients and families. The organization supports the development and scientific research in the field through the collaboration of various healthcare professionals. It offers clinical guidelines, a biobank, and a job portal for professionals. The group also organizes educational events and training programs.
GETH has 1 investor. Key investors include European Union.